Speciality Chemicals — sector analysis & key numbers
Speciality Chemicals is turning around off a trough: 12 of 25 constituents are in price uptrends, and aggregate profit grew 14% in the latest year.
Speciality Chemicals groups 26 listed companies worth ₹2,99,964 Cr combined, and 12 of 25 are in confirmed price uptrends. Aggregate profit moved +24.9% year-on-year in the latest reported quarter. The sector trades at an aggregate P/E of 43.1×, at the 54th percentile of its own history.
Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.
- Companies
- 26
- Total market cap
- ₹2,99,964 Cr
- Relative strength
- 43.8
- RRG quadrant
- narrowing
- Weeks in streak
- 12
- In Stage-2 uptrend
- 12 of 25
- Above 200-DMA
- 15 of 25
- Beating NIFTY 500
- 14 of 25
- Latest-quarter revenue
- ₹13,503 Cr
- Latest-quarter profit
- ₹1,465 Cr
- Aggregate P/E
- 43.1×
- Valuation percentile
- 54th of its own history
- Sector wind
- tailwind
- Data as of
- 1 July 2026
The research read on Speciality Chemicals: turning around off a trough.lifecycle_bucket
The tri-stream verdict isolates a durable specialty cohort from a struggling commodity base. The curve shows an earnings-led de-rating, with ΣPAT up +14.2% YoY driven by revenue expansion, bringing the aggregate PE down to a fairly priced 43.1 (40th percentile). Qual corroborates this as an early recovery off a destocking trough, anchored by structural China+1 outsourcing and new energy-transition (battery materials) layers. However, social sentiment is weak (48) and qual flags high near-term risks due to the Hormuz blockade spiking ammonia/sulfur costs and Chinese dumping compressing commodity spreads. Consequently, the call is a selective worth studying deeper into the specialty/CDMO leaders driving the growth (like Pidilite and Privi), while avoiding the commodity laggards.synthesis
What would change this view: A quarterly print showing sustained Chinese dumping that permanently rebases specialty margins downwards or failure of the newly commercialized battery materials and CDMO capacities to scale.would_change_my_mind
Early post-destocking recovery — volumes rebounding off the FY25 trough with China+1/CDMO multi-year contracts and a structural battery-materials layer, but margins still hostage to a Hormuz feedstock spike and Chinese commodity dumping.one_line_thesis
- ⚠Aggregate revenue expanded +13.4% and PAT +14.2% YoY (2025-2026). · sector_why_traces (annual YoY)
- ⚠Operating margins sit at 18.29%, tracking near the 12y mid-cycle norm of 18.12%. · sector_cycle_deterministic.verdict
- ✓Trailing PE has de-rated 18.7% from 52.99 to 43.1. · curve.valuation_series.pe
- ⚠Trailing PE is in the 40th percentile historically. · sector_cycle_deterministic.pe
- ⚠The curve move is earnings-led, with PAT up +24% leading multiple contraction of 18.7%. · sector_cycle_deterministic.curve_move_driver
- ⚠Pidilite, Privi lifted PAT; Thirumalai dragged PAT. · sector_cycle_deterministic.top_contributors
- ✓A quiet recovery taking shape on volumes, plus a structural CDMO and battery-materials growth layer. · qual.q1_fundamentals.headline
- ✓China+1 outsourcing and CDMO contract wins. · qual.triggers_identified
Research view from 2026-06-27
Across the 4 largest constituents with research timelines, 3 carried trackable guidance: 5 beats, 0 met, 14 misses against what management said.guidance_pairs
Research view from 2026-06-27
12 of 25 constituents are in Stage-2 price uptrends, 15 trade above their 200-day averages, and 14 are beating the NIFTY 500 on relative strength.stageabove_dma200rs_mansfield
Over the trailing ~20 weeks, the share of constituents above the 200-day line moved from 25% to 71% — participation is widening.breadth_series
Sector relative strength stands at 43.8, in the narrowing quadrant of the rotation map, with relative strength rising over a 12-week streak.current_rsquadrant
Recent stage changes: 530477 (stage 4→2), 530845 (stage 4→2), DMCC (stage 4→3), FCL (stage 4→2).stage
Data: Breadth trend
| Period | % above 200-DMA (%) | % beating NIFTY (%) |
|---|---|---|
| Feb 26 | 25.0 | 25.0 |
| Feb 26 | 25.0 | 25.0 |
| Feb 26 | 33.3 | 37.5 |
| Mar 26 | 16.7 | 25.0 |
| Mar 26 | 21.7 | 26.1 |
| Mar 26 | 21.7 | 30.4 |
| Mar 26 | 17.4 | 26.1 |
| Mar 26 | 44.4 | 66.7 |
| Apr 26 | 46.7 | 46.7 |
| Apr 26 | 41.7 | 37.5 |
| Apr 26 | 33.3 | 37.5 |
| Apr 26 | 37.5 | 33.3 |
| May 26 | 62.5 | 54.2 |
| May 26 | 62.5 | 58.3 |
| May 26 | 58.3 | 62.5 |
| May 26 | 58.3 | 54.2 |
| Jun 26 | 66.7 | 66.7 |
| Jun 26 | 62.5 | 58.3 |
| Jun 26 | 66.7 | 54.2 |
| Jun 26 | 70.8 | 58.3 |
Data as of 2026-07-01
Top performers by 1-year price return: Aether Industries Ltd (+70.4%), Sunshield Chemicals Ltd (+56.7%), Privi Speciality Chemicals Ltd (+49.2%), Yasho Industries Ltd (+45.3%), Fineotex Chemical Ltd (+38.7%).price
Data: Indexed price (base 100, ~52 weeks) — default top-5
| Period | AETHER (index) | 530845 (index) | PRIVISCL (index) | YASHO (index) | FCL (index) | Sector avg (index) |
|---|---|---|---|---|---|---|
| Jul 25 | 100 | 100 | 100 | 100 | 100 | 100 |
| Jul 25 | 106 | 99.5 | 101 | 99.7 | 103 | 104 |
| Jul 25 | 100 | 96.9 | 103 | 98.3 | 99.6 | 102 |
| Aug 25 | 96.8 | 124 | 101 | 91.9 | 94.2 | 102 |
| Aug 25 | 94.3 | 117 | 101 | 88.5 | 87.0 | 99.2 |
| Aug 25 | 95.2 | 112 | 101 | 87.4 | 86.3 | 98.6 |
| Aug 25 | 99.1 | 125 | 100 | 85.3 | 94.2 | 100 |
| Aug 25 | 94.5 | 125 | 91.5 | 90.9 | 88.0 | 97.3 |
| Sep 25 | 95.2 | 136 | 94.4 | 90.9 | 87.4 | 98.9 |
| Sep 25 | 94.2 | 135 | 96.7 | 88.7 | 87.5 | 99.5 |
| Sep 25 | 94.5 | 126 | 101 | 86.1 | 87.0 | 101 |
| Sep 25 | 94.4 | 121 | 97.7 | 83.1 | 92.5 | 98.3 |
| Oct 25 | 97.2 | 126 | 100 | 82.7 | 92.5 | 99.7 |
| Oct 25 | 96.4 | 125 | 104 | 82.4 | 90.3 | 98.3 |
| Oct 25 | 95.8 | 119 | 112 | 79.9 | 90.3 | 97.3 |
| Oct 25 | 98.2 | 119 | 121 | 80.6 | 94.5 | 98.4 |
| Oct 25 | 96.8 | 135 | 120 | 79.5 | 110 | 99.0 |
| Nov 25 | 94.6 | 131 | 140 | 79.5 | 97.3 | 97.8 |
| Nov 25 | 108 | 130 | 134 | 87.4 | 95.2 | 96.3 |
| Nov 25 | 118 | 149 | 130 | 82.8 | 90.9 | 96.3 |
| Nov 25 | 113 | 134 | 130 | 80.6 | 92.9 | 95.1 |
| Dec 25 | 109 | 132 | 132 | 79.1 | 93.8 | 92.6 |
| Dec 25 | 111 | 124 | 127 | 78.8 | 90.2 | 92.0 |
| Dec 25 | 108 | 120 | 128 | 72.0 | 88.6 | 92.1 |
| Dec 25 | 109 | 120 | 135 | 72.7 | 93.0 | 92.9 |
| Jan 26 | 121 | 120 | 115 | 72.0 | 90.4 | 93.4 |
| Jan 26 | 126 | 116 | 112 | 68.9 | 85.8 | 89.2 |
| Jan 26 | 127 | 109 | 110 | 64.6 | 84.8 | 88.7 |
| Jan 26 | 124 | 110 | 112 | 62.1 | 80.2 | 84.8 |
| Feb 26 | 129 | 108 | 116 | 60.4 | 82.2 | 84.4 |
| Feb 26 | 130 | 109 | 114 | 69.7 | 84.2 | 87.3 |
| Feb 26 | 124 | 108 | 113 | 68.9 | 88.8 | 87.9 |
| Feb 26 | 124 | 109 | 120 | 74.5 | 92.0 | 87.6 |
| Feb 26 | 123 | 111 | 126 | 78.4 | 87.2 | 86.7 |
| Mar 26 | 130 | 107 | 120 | 78.5 | 80.9 | 83.5 |
| Mar 26 | 129 | 103 | 118 | 65.3 | 81.2 | 82.3 |
| Mar 26 | 148 | 104 | 121 | 71.0 | 80.4 | 83.3 |
| Mar 26 | 150 | 97.6 | 122 | 68.3 | 74.5 | 80.3 |
| Apr 26 | 142 | – | 122 | – | – | 100 |
| Apr 26 | 153 | 101 | 120 | 73.8 | 86.3 | 97.0 |
| Apr 26 | 152 | 117 | 130 | 77.2 | 85.7 | 91.8 |
| Apr 26 | 143 | 113 | 134 | 73.8 | 84.6 | 91.2 |
| Apr 26 | 151 | 113 | 139 | 75.1 | 84.8 | 93.4 |
| May 26 | 156 | 118 | 144 | 78.2 | 104 | 98.8 |
| May 26 | 143 | 118 | 128 | 84.8 | 93.9 | 94.9 |
| May 26 | 135 | 113 | 137 | 101 | 123 | 96.7 |
| May 26 | 141 | 133 | 135 | 103 | 148 | 98.4 |
| Jun 26 | 146 | 139 | 134 | 123 | 150 | 102 |
| Jun 26 | 147 | 156 | 142 | 145 | 145 | 103 |
| Jun 26 | 149 | 158 | 145 | 144 | 161 | 107 |
| Jun 26 | 170 | 154 | 147 | 144 | 151 | 106 |
| Jul 26 | 170 | 160 | 152 | 154 | 141 | 108 |
Data: Quarterly revenue (8q) — default top-5
| Period | AETHER (₹ Cr) | 530845 (₹ Cr) | PRIVISCL (₹ Cr) | YASHO (₹ Cr) | FCL (₹ Cr) | Sector avg (₹ Cr) |
|---|---|---|---|---|---|---|
| Jun 24 | 180 | 78.0 | 464 | 174 | 142 | 452 |
| Sep 24 | 199 | 93.0 | 533 | 167 | 146 | 450 |
| Dec 24 | 220 | 85.0 | 491 | 149 | 126 | 466 |
| Mar 25 | 240 | 110 | 614 | 185 | 120 | 489 |
| Jun 25 | 256 | 114 | 559 | 199 | 137 | 494 |
| Sep 25 | 280 | 122 | 679 | 183 | 138 | 530 |
| Dec 25 | 319 | 95.0 | 605 | 202 | 184 | 536 |
| Mar 26 | 305 | 110 | 722 | 246 | 314 | 581 |
Data: Quarterly net profit (8q) — default top-5
| Period | AETHER (₹ Cr) | 530845 (₹ Cr) | PRIVISCL (₹ Cr) | YASHO (₹ Cr) | FCL (₹ Cr) | Sector avg (₹ Cr) |
|---|---|---|---|---|---|---|
| Jun 24 | 30.0 | 4.0 | 31.0 | -2.0 | 29.0 | 50.9 |
| Sep 24 | 35.0 | 3.0 | 45.0 | 4.0 | 32.0 | 49.0 |
| Dec 24 | 43.0 | 2.0 | 44.0 | -1.0 | 28.0 | 48.8 |
| Mar 25 | 50.0 | 6.0 | 64.0 | 5.0 | 20.0 | 48.0 |
| Jun 25 | 47.0 | 7.0 | 58.0 | 4.0 | 25.0 | 54.3 |
| Sep 25 | 54.0 | 7.0 | 90.0 | 5.0 | 26.0 | 55.3 |
| Dec 25 | 64.0 | 5.0 | 75.0 | 4.0 | 30.0 | 55.8 |
| Mar 26 | 54.0 | 11.0 | 94.0 | 12.0 | 44.0 | 63.4 |
Data: Operating margin % (8q) — default top-5
| Period | AETHER (%) | 530845 (%) | PRIVISCL (%) | YASHO (%) | FCL (%) | Sector avg (%) |
|---|---|---|---|---|---|---|
| Jun 24 | 24.0 | 10.0 | 20.0 | 13.0 | 25.0 | 18.7 |
| Sep 24 | 27.0 | 8.0 | 21.0 | 19.0 | 25.0 | 19.1 |
| Dec 24 | 29.0 | 8.0 | 23.0 | 18.0 | 27.0 | 20.4 |
| Mar 25 | 33.0 | 10.0 | 22.0 | 19.0 | 18.0 | 18.0 |
| Jun 25 | 32.0 | 11.0 | 24.0 | 17.0 | 18.0 | 19.3 |
| Sep 25 | 31.0 | 11.0 | 27.0 | 18.0 | 23.0 | 18.4 |
| Dec 25 | 35.0 | 10.0 | 25.0 | 17.0 | 19.0 | 18.0 |
| Mar 26 | 27.0 | 15.0 | 25.0 | 18.0 | 14.0 | 18.7 |
Data: Latest reported ROCE / ROE (single latest reading, not a trend) — default top-5
| Period | AETHER (%) | 530845 (%) | PRIVISCL (%) | YASHO (%) | FCL (%) | Sector avg (%) |
|---|---|---|---|---|---|---|
| ROCE % | 11.9 | 19.9 | 22.1 | 9.0 | 18.3 | 17.0 |
| ROE % | 9.7 | 17.0 | 26.0 | 5.8 | 13.5 | 13.9 |
Data: 10-year valuation percentile (latest) — default top-5
| Period | AETHER (percentile) | 530845 (percentile) | PRIVISCL (percentile) | YASHO (percentile) | FCL (percentile) | Sector avg (percentile) |
|---|---|---|---|---|---|---|
| 10y percentile | 28.0 | 33.0 | 51.0 | 80.0 | 91.0 | 49.8 |
Interactive charts default to the five strongest performers by 1-year price return; use the rail to add or remove any constituent, globally or per chart. Non-interactive readers see the same numbers in each chart’s data table.
Data as of 2026-07-01
In the latest reported quarter (2026-03), constituents together booked ₹13,503 Cr of revenue (+13.4% year-on-year) and ₹1,465 Cr of profit (+24.9%).revenuepat
Reporting honesty note: 24 of the constituents have reported this quarter versus 25 a year ago, so part of the year-on-year change is composition, not like-for-like growth.reporters
On the annual arc, aggregate profit grew 14% to ₹5,452 Cr in 2026.pat
Data: Aggregate quarterly revenue
| Period | Revenue (₹ Cr) | Reporters |
|---|---|---|
| Jun 23 | 10,010 | 25 |
| Sep 23 | 10,052 | 25 |
| Dec 23 | 10,094 | 25 |
| Mar 24 | 10,646 | 25 |
| Jun 24 | 11,001 | 25 |
| Sep 24 | 10,954 | 25 |
| Dec 24 | 11,342 | 25 |
| Mar 25 | 11,904 | 25 |
| Jun 25 | 12,011 | 25 |
| Sep 25 | 12,870 | 25 |
| Dec 25 | 13,028 | 25 |
| Mar 26 | 13,503 | 24 |
Data: Aggregate quarterly profit
| Period | Profit after tax (₹ Cr) |
|---|---|
| Jun 23 | 1,078 |
| Sep 23 | 1,086 |
| Dec 23 | 1,118 |
| Mar 24 | 1,000 |
| Jun 24 | 1,232 |
| Sep 24 | 1,186 |
| Dec 24 | 1,181 |
| Mar 25 | 1,173 |
| Jun 25 | 1,318 |
| Sep 25 | 1,338 |
| Dec 25 | 1,350 |
| Mar 26 | 1,465 |
Data: Aggregate operating margin
| Period | OPM (%) |
|---|---|
| Jun 23 | 18.1 |
| Sep 23 | 18.3 |
| Dec 23 | 18.5 |
| Mar 24 | 17.1 |
| Jun 24 | 18.8 |
| Sep 24 | 17.9 |
| Dec 24 | 18.3 |
| Mar 25 | 17.3 |
| Jun 25 | 18.7 |
| Sep 25 | 18.0 |
| Dec 25 | 18.0 |
| Mar 26 | 18.4 |
Data: Aggregate profit by year
| Period | Profit after tax (₹ Cr) |
|---|---|
| 2015 | 975 |
| 2016 | 1,457 |
| 2017 | 1,748 |
| 2018 | 2,132 |
| 2019 | 2,484 |
| 2020 | 3,264 |
| 2021 | 3,344 |
| 2022 | 4,776 |
| 2023 | 4,398 |
| 2024 | 4,277 |
| 2025 | 4,772 |
| 2026 | 5,452 |
Data: Operating margin by year
| Period | OPM (%) |
|---|---|
| 2015 | 13.6 |
| 2016 | 17.8 |
| 2017 | 18.3 |
| 2018 | 17.8 |
| 2019 | 18.1 |
| 2020 | 20.2 |
| 2021 | 21.2 |
| 2022 | 20.2 |
| 2023 | 17.2 |
| 2024 | 18.0 |
| 2025 | 18.1 |
| 2026 | 18.3 |
Data as of 2026-06-27
Sector profit moved from ₹4,772 Cr to ₹5,452 Cr (+14.2% year-on-year) — the decomposition attributes the larger share to the revenue side (demand and volumes).pat
Sector revenue moved from ₹45,189 Cr to ₹51,236 Cr (+13.4% year-on-year).revenue
Participation check: the share of constituents above their 200-day average moved 25%→67% across the trailing weeks — the move is broadening.pct_above_200dma
Sector ΣPAT +14.2% YoY — dominant leg: revenue (volume/demand-led — the durable kind).
patSector Σrevenue +13.4% YoY — confirm it is demand/volume-led across constituents, not price/base.
revenueSector breadth WIDENING — % above 200-DMA 25→67% over the trailing weeks: broad participation corroborates a genuine sector-wide turn rather than a few-name move.
pct_above_200dmapct_outperformingResearch view from 2026-06-27
Ownership: institutional (FII+DII) holdings moved +1.28 percentage points over four quarters; promoter stakes moved -0.14 points over two.fii_dii_delta_4qpromoter_delta_2q
Constituents spent ₹7,640 Cr on capex in the trailing twelve months (+12.9% year-on-year), with gross block growing +14%.capex_ttm_sum_crcapex_yoy_pct
On the deterministic capital-flow read, money is neither decisively entering nor leaving this industry.read
Research view from 2026-06-27
The sector trades at an aggregate P/E of 43.1× against a range of 30.32–79.64× over its 40-quarter history.pe
The median constituent sits at the 54th percentile of its own 10-year valuation range.percentile
Data: Aggregate P/E and price index
| Period | P/E (×) | Price index |
|---|---|---|
| Jun 16 | 33.9 | 100 |
| Sep 16 | 33.3 | 100 |
| Dec 16 | 30.3 | 92 |
| Mar 17 | 31.7 | 109 |
| Jun 17 | 35.9 | 124 |
| Sep 17 | 36.3 | 126 |
| Dec 17 | 43.5 | 150 |
| Mar 18 | 35.6 | 145 |
| Jun 18 | 38.9 | 159 |
| Sep 18 | 37.8 | 157 |
| Dec 18 | 40.3 | 171 |
| Mar 19 | 39.4 | 187 |
| Jun 19 | 39.4 | 193 |
| Sep 19 | 44.4 | 218 |
| Dec 19 | 42.5 | 210 |
| Mar 20 | 31.7 | 180 |
| Jun 20 | 38.3 | 217 |
| Sep 20 | 43.1 | 244 |
| Dec 20 | 50.0 | 283 |
| Mar 21 | 52.7 | 312 |
| Jun 21 | 67.2 | 398 |
| Sep 21 | 76.4 | 438 |
| Dec 21 | 79.6 | 457 |
| Mar 22 | 56.5 | 443 |
| Jun 22 | 48.7 | 374 |
| Sep 22 | 57.6 | 443 |
| Dec 22 | 53.0 | 407 |
| Mar 23 | 53.0 | 375 |
| Jun 23 | 59.1 | 416 |
| Sep 23 | 57.4 | 396 |
| Dec 23 | 62.0 | 432 |
| Mar 24 | 62.2 | 431 |
| Jun 24 | 65.5 | 469 |
| Sep 24 | 67.2 | 492 |
| Dec 24 | 59.1 | 438 |
| Mar 25 | 52.4 | 402 |
| Jun 25 | 58.6 | 458 |
| Sep 25 | 53.3 | 429 |
| Dec 25 | 51.2 | 425 |
| Mar 26 | 43.1 | 378 |
Data as of 2026-06-27
25 companies make up this sector, led by Pidilite Industries Ltd at ₹1,62,539 Cr of market value.constituents
| Company | Price | 1y | Stage | RS | 10y val % |
|---|---|---|---|---|---|
| Pidilite Industries Ltd | ₹1,582 | +2.7% | 4 | 7.4 | 42 |
| Aether Industries Ltd | ₹1,327 | +70.4% | 2 | 40.0 | 28 |
| Aarti Industries Ltd | ₹468 | −1.9% | 2 | 13.1 | 72 |
| Anupam Rasayan India Ltd | ₹1,271 | +11.8% | 2 | 3.5 | 65 |
| Vinati Organics Ltd | ₹1,324 | −31.9% | 4 | -14.0 | 5 |
| Privi Speciality Chemicals Ltd | ₹3,684 | +49.2% | 2 | 26.9 | 51 |
| Alkyl Amines Chemicals Ltd | ₹1,766 | −23.1% | 4 | 1.5 | 53 |
| Clean Science & Technology Ltd | ₹759 | −48.8% | 4 | -17.9 | 5 |
| Galaxy Surfactants Ltd | ₹1,967 | −24.0% | 4 | -3.9 | 31 |
| Neogen Chemicals Ltd | ₹2,014 | +24.6% | 2 | 38.2 | 97 |
| Fineotex Chemical Ltd | ₹38.1 | +38.7% | 2 | 44.4 | 91 |
| Vishnu Chemicals Ltd | ₹604 | +18.0% | 2 | 15.0 | 88 |
| Yasho Industries Ltd | ₹3,064 | +45.3% | 2 | 77.9 | 80 |
| Grauer & Weil (India) Ltd | ₹83.5 | −19.4% | 4 | 6.3 | 67 |
| Tatva Chintan Pharma Chem Ltd | ₹1,189 | +18.1% | 2 | -1.8 | 24 |
| Panama Petrochem Ltd | ₹417 | +17.6% | 2 | 36.0 | 65 |
| Thirumalai Chemicals Ltd | ₹179 | −36.6% | 4 | -22.8 | – |
| Paushak Ltd | ₹511 | −16.4% | 4 | -12.8 | 56 |
| Platinum Industries Ltd | ₹223 | −18.8% | 4 | -10.5 | 18 |
| Amines & Plasticizers Ltd | ₹192 | −21.5% | 4 | -0.8 | 77 |
| Sunshield Chemicals Ltd | ₹1,218 | +56.7% | 2 | 31.9 | 33 |
| Chemcon Speciality Chemicals Ltd | ₹188 | −5.5% | 4 | -5.8 | 54 |
| Vikram Thermo (India) Ltd | ₹235 | – | 2 | 42.6 | 56 |
| Amal Ltd | ₹508 | −21.6% | 4 | -26.3 | 6 |
| DMCC Speciality Chemicals Ltd | ₹253 | −2.5% | 3 | -6.6 | 31 |
Data as of 2026-07-01
Tailwind chain: The shared driver is the strategy's own setup: turning around / oversold value buckets where earnings have troughed and turned, the multiple has de-rated to decade-cheap, and a CONFIRMING RRG start is present… Also touches: Logistics, IT Product Companies, Aerospace & Defence - Equipments.triggermechanism
Tailwind chain: The full PLI/SPECS/ECMS/Semiconductor-Mission policy stack + China+1 reshoring, cited as the strongest structural thesis in the batch by Consumer Electronics - EMS, and as the demand pull in Electronics - Others — set… Also touches: Consumer Electronics - EMS, Electronics - Others.triggermechanism
The shared driver is the strategy's own setup: turning around / oversold value buckets where earnings have troughed and turned, the multiple has de-rated to decade-cheap, and a CONFIRMING RRG start is present — Speciality Chemicals (RECOVERY, rrg 60.2), Diagnostics (turning around, conv 70), Logistics (fairly priced real value, rrg confirming), Realty - CoWorking (profitability cross confirmed, rrg 81.6), IT Product Companies (oversold value, rrg 88.3).
A genuine fundamental inflection off a depressed base with price just beginning to move is the §0 base-rate winner pattern (depressed-base + EPS-support = 734% avg vs 287% cohort). These are NOT linked by a macro driver but by SETUP quality — they are the freshest points on the curve and per doctrine RANK ABOVE the topping/peak-margin names regardless of headline conviction.
The full PLI/SPECS/ECMS/Semiconductor-Mission policy stack + China+1 reshoring, cited as the strongest structural thesis in the batch by Consumer Electronics - EMS, and as the demand pull in Electronics - Others — set against a real FY27 margin air-pocket (mobile-PLI expiry, +22-35% wage hikes, rupee at Rs95, Kaynes -21% PAT) [Consumer Electronics-EMS Q4/Q5].
Policy incentives + supply-chain relocation pull electronics/EMS volumes onshore → earnings-led inflection in backward-integrating leaders, with adjacent demand for speciality-chemical and bulk-drug inputs. But the same transition imposes a near-term FY27 margin trough (PLI expiry, wage/rupee/memory-cost) and is triggering a capex supply flood (EMS capex +59.2%/GB +61.7%/CWIP +81%; Electronics-Others capex +2,175% with institutions FLEEING).
Research view from 2026-06-27
Institutional money is NOT yet crowding in: FII+DII holdings moved just +0.4 percentage points across constituents over the last two quarters — the capital-flow read is neutral.fii_dii_delta_2qread
- Institutional money is NOT yet crowding in: FII+DII holdings moved just +0.4 percentage points across constituents over the last two quarters — the capital-flow read is neutral.
Data as of 2026-07-01
Straight answers from the data
What is the Speciality Chemicals sector?
The Speciality Chemicals sector groups 26 listed companies with a combined market value of ₹2,99,964 Cr, led by Pidilite Industries Ltd, Aether Industries Ltd, Aarti Industries Ltd. 12 of 25 constituents are currently in confirmed price uptrends.
Which stocks are in the Speciality Chemicals sector?
The largest Speciality Chemicals companies by market value are Pidilite Industries Ltd (₹1,62,539 Cr), Aether Industries Ltd (₹17,586 Cr), Aarti Industries Ltd (₹16,919 Cr), Anupam Rasayan India Ltd (₹14,585 Cr), Vinati Organics Ltd (₹14,362 Cr), Privi Speciality Chemicals Ltd (₹13,869 Cr), Alkyl Amines Chemicals Ltd (₹9,112 Cr), Clean Science & Technology Ltd (₹8,381 Cr).
What are the best-performing Speciality Chemicals stocks?
By 1-year price return as of 1 July 2026, the strongest Speciality Chemicals stocks are Aether Industries Ltd (+70%), Sunshield Chemicals Ltd (+57%), Privi Speciality Chemicals Ltd (+49%), Yasho Industries Ltd (+45%), Fineotex Chemical Ltd (+39%). These are descriptive price moves measured from weekly Screener closes, not recommendations.
Is the Speciality Chemicals sector in an uptrend?
12 of 25 Speciality Chemicals constituents are in Stage-2 price uptrends, 15 trade above their 200-day average, and 14 are beating the NIFTY 500 on relative strength. Sector relative strength reads 43.8, in the narrowing quadrant of the rotation map, rising over a 12-week streak.
How many Speciality Chemicals stocks trade above their 200-day average?
15 of 25 Speciality Chemicals constituents currently trade above their 200-day moving average. Over the trailing ~20 weeks, that share moved from 25% to 71% — participation is widening.
Is the Speciality Chemicals sector expensive versus its own history?
The Speciality Chemicals sector trades at an aggregate P/E of 43.1× against a 30.3–79.6× band over its own history. The median constituent sits at the 54th percentile of its own 10-year P/E range, around the middle of its own historical range.
Is money entering or leaving the Speciality Chemicals sector?
On Sector Alpha's deterministic capital-flow read, money is neither clearly entering nor leaving the Speciality Chemicals sector. Institutional (FII+DII) holdings moved +1.28 percentage points across constituents over the last four quarters, and constituents grew capex +12.9% year-on-year.
How fast is the Speciality Chemicals sector growing?
In the latest reported quarter (March 2026), Speciality Chemicals constituents together booked ₹13,503 Cr of revenue, +13.4% year-on-year, with aggregate profit +24.9% year-on-year. Figures aggregate Screener-scraped quarterly filings across the sector.
How are Speciality Chemicals operating margins trending?
Aggregate Speciality Chemicals operating margin was 18.4% in the latest reported quarter (March 2026), versus 17.3% a year earlier — margins are improving.
Which sectors is the Speciality Chemicals sector connected to?
The Speciality Chemicals sector sits in 2 cross-sector chains: as a beneficiary it connects to Logistics, IT Product Companies, Aerospace & Defence - Equipments — The shared driver is the strategy's own setup: turning around / oversold value buckets where earnings have troughed and turned, the multiple has de-rated to…; as a beneficiary it connects to Consumer Electronics - EMS, Electronics - Others — The full PLI/SPECS/ECMS/Semiconductor-Mission policy stack + China+1 reshoring, cited as the strongest structural thesis in the batch by Consumer Electronics - EMS, and….
What is the bull case for the Speciality Chemicals sector?
Early post-destocking recovery — volumes rebounding off the FY25 trough with China+1/CDMO multi-year contracts and a structural battery-materials layer, but margins still hostage to a Hormuz feedstock spike and Chinese commodity dumping. Trailing PE has de-rated 18.7% from 52.99 to 43.1.
What could change the view on the Speciality Chemicals sector?
A quarterly print showing sustained Chinese dumping that permanently rebases specialty margins downwards or failure of the newly commercialized battery materials and CDMO capacities to scale. Also worth noting: institutional money is NOT yet crowding in: FII+DII holdings moved just +0.4 percentage points across constituents over the last two quarters — the capital-flow read is neutral.
What is the research view on the Speciality Chemicals sector?
Sector Alpha does not publish trading recommendations or price calls — this is a research read, not advice. What the data says: turning around · mixed. The tri-stream verdict isolates a durable specialty cohort from a struggling commodity base. The curve shows an earnings-led de-rating, with ΣPAT up +14.2% YoY driven by revenue expansion, bringing the aggregate PE down to a fairly priced 43.1 (40th percentile). Every number on this page traces to its source column; it is machine-written research, not investment advice.
Should I invest in the Speciality Chemicals sector?
Sector Alpha does not publish sector allocations or trading calls — for Speciality Chemicals or any sector. What this page provides is a data-first read: how many constituents are in confirmed uptrends, how the sector's valuation compares with its own history, where earnings sit in their cycle, and whether capital is entering or leaving. Use it to study the sector on the evidence, then do your own diligence.
What is the Speciality Chemicals sector's relative-strength position?
Speciality Chemicals relative strength reads 43.8 on Sector Alpha's rotation map, placing it in the narrowing quadrant. Relative strength is rising and has held for 12 weeks. A positive, rising relative-strength trend means the sector has been outperforming the broad market week after week.